missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Villin 1 Rabbit anti-Human, Clone: VIL1/4107R, Novus Biologicals™

Villin 1 Rabbit anti-Human, Clone: VIL1/4107R, Novus Biologicals™

Rabbit Monoclonal Antibody

297.00 €

Specifications

Antigen Villin 1
Clone VIL1/4107R
Concentration 0.2 mg/ml
Dilution Immunohistochemistry-Paraffin 1-2 ug/ml
Applications Immunohistochemistry (Paraffin)
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18393972
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP3-07190-20UG 		20 μg
297.00 €
20µg
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Villin 1 Monoclonal specifically detects Villin 1 in Human samples. It is validated for Immunohistochemistry-Paraffin.
Specifications

Specifications

Villin 1
0.2 mg/ml
Immunohistochemistry (Paraffin)
Unconjugated
Rabbit
Cancer, Cell Biology, Cellular Markers
10 mM PBS with 0.05% BSA
7429
IgG
Protein A or G purified
VIL1/4107R
Immunohistochemistry-Paraffin 1-2 ug/ml
Monoclonal
Purified
RUO
Human
D2S1471, VIL, villin 1, villin-1
Recombinant fragment (around aa600-700) of human Villin 1 protein (exact sequence is proprietary)
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.